维普中文期刊产品整合服务
15篇 您的检索式:作者名="Satman I"
    题名 作者 年代 出处 被引量
1Comparison of acarbose and gliclazide as first - line agents in patients with type 2 diabetes 显示文摘Salman S Salman f Satman I 2001Curr Med Res Opin2001,16,4:1
2Comparison of acarbose and gliclazide as first -line agents in patients with type 2 diabetes显示文摘Salman S Salman F Satman I 2001Curr Med Res Opin2001,16,4:1
3Population-based study of diabetes and risk characteristics in turkey显示文摘Satman I Sargin M Yilmaz T 2002Diabetes Care2002,25,9:1
4Comparison of acarbose and gliclazideas first-line agents in patients with type 2 diabetes显示文摘Salman S Salman F Satman I 2001Curr Med Res Opin2001,16,4:1
5Comparison of acarbose and gliclazide as {irst-line agents in patients with type 2 diabetes显示文摘Salman S Salman F Satman I 2001Curt Med Res Opin2001,16,4:1
6Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents显示文摘Philis-Tsimikas A Delprato S Satman I 2013Diabetes Obes Metab2013,15,8:1
7Population - based study of diabetes and risk charaeteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP) 显示文摘Satman I Yilmaz T Sengul A 2002Diabetes care2002,25,9:1
8Evalution of insulin resistant diabetes mellitus in Alstron syndrome:a long-term prospective follow-up of three siblings显示文摘Satman I Yilmaz MT Gursoy N Karsidag K Dinccag N Ovali T 2002Diabetes Res Clin Pract2002,56,3:1
9Population-based study of diabetes and risk characteristics in Turkey : results of the turkish diabetes epidemiology study (TURDEP) 显示文摘Satman I Yilmaz T Sengul A 2002Diabetes Care2002,25,9:1
10Population-based study of diabetes and risk characteristics in turkey显示文摘Satman I Sargin M Yilmaz T 2002Diabetes Care2002,25,9:1
11Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes显示文摘Salman S Salman F Satman I 2001Curr Med Res Opin2001,16,4:1
12Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes显示文摘 Salman F Satman I 2001Curr Med Res Opin2001,16,4:1
13Sensitivity of FRAMING- HAM, PROCAM and SCORE models in Turkish people with Type 2 diabetes: comparison of three cardiovascular risk calculations 显示文摘Baym&r (evik A Ozcan Satman I 2015Contemp Nurse2015,50,23:1
14Population-based study of diabetes and risk characteristics in turkey显示文摘Satman I Sargin M Yilmaz T 2002Diabetes Care2002,25,:1
15Rates and associates of influenza and pneumococcus vaccination in diabetes mellitus:A nationwide cross-sectional study(TEMD vaccination study)显示文摘BACKGROUND Vaccination against influenza and pneumococcus is effective in reducing morbidity and mortality in patients with diabetes.AIM To investigate the prevalence of influenza and pneumococcal vaccinations and to search for the independent associates of vaccination in Turkish patients with diabetes.METHODS In this cross-sectional,nationwide,multicenter study,adult patients with type 1 diabetes(T1DM)(n=454)and type 2 diabetes(T2DM)(n=4721),who were under follow-up for at least a year in the outpatient clinics,were consecutively enrolled.Sociodemographic,clinical,and laboratory parameters of patients were recorded.Vaccination histories were documented according to the self-statements of the patients.RESULTS Patients with T1DM and T2DM had similar vaccination rates for influenza(23.6%vs 21.2%;P=0.240)and pneumococcus(8%vs 7%;P=0.451)vaccinations.Longer diabetes duration and older age were the common independent associates of having vaccination for both types of diabetes patients.Higher education level,using statin treatment,and having optimal hemoglobin A1c levels were the common independent associates of influenza and pneumococcal vaccination in patients with T2DM.CONCLUSION TEMD Vaccination Study shows that patients with T1DM and T2DM had very low influenza and pneumococcal vaccination rates in Turkey.The lower rates of vaccination in certain populations urges the necessity of nationwide vaccination strategies targeting these populations.Ibrahim Demirci Cem Haymana Serpil Salman Ilker Tasci Demet Corapcioglu Ali Kirik İlhan Yetkin Mustafa Altay Tevfik Sabuncu Fahri Bayram Ilhan Satman Alper Sonmez 2021World Journal of Diabetes2021,12,12:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费